Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Giamarellou

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Antimicrobial Agents|December 7, 2010
Multidrug-resistant Gram-negative bacteria: how to treat and for how longHelen Giamarellou
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Prescribing guidelines for severe Pseudomonas infectionsHelen Giamarellou
International Journal of Antimicrobial Agents|November 21, 2016
Epidemiology of infections caused by polymyxin-resistant pathogensHelen Giamarellou
Expert Review of Anti-Infective Therapy|October 3, 2006
Treatment options for multidrug-resistant bacteriaHelen Giamarellou
Infectious Disease Clinics of North America|December 7, 2007
Fever of unknown origin in febrile leukopeniaAnastasia Antoniadou, Helen Giamarellou
Expert Opinion on Investigational Drugs|January 25, 2007
Investigational treatments for postoperative surgical site infectionsGaryphallia Poulakou, Helen Giamarellou
Antibiotics (Basel, Switzerland)|February 9, 2020
Carbapenem-Sparing Strategies for ESBL Producers: When and HowIlias Karaiskos, Helen Giamarellou
Drugs|September 15, 2009
Multidrug-resistant Gram-negative infections: what are the treatment options?Helen Giamarellou, Garyphallia Poulakou
Expert Opinion on Pharmacotherapy|April 29, 2014
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approachesIlias Karaiskos, Helen Giamarellou
Critical Care Clinics|March 26, 2008
Current therapies for pseudomonas aeruginosaHelen Giamarellou, Kyriaki Kanellakopoulou
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Antimicrobial Agents|December 7, 2010
Multidrug-resistant Gram-negative bacteria: how to treat and for how longHelen Giamarellou
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Prescribing guidelines for severe Pseudomonas infectionsHelen Giamarellou
International Journal of Antimicrobial Agents|November 21, 2016
Epidemiology of infections caused by polymyxin-resistant pathogensHelen Giamarellou
Expert Review of Anti-Infective Therapy|October 3, 2006
Treatment options for multidrug-resistant bacteriaHelen Giamarellou
Infectious Disease Clinics of North America|December 7, 2007
Fever of unknown origin in febrile leukopeniaAnastasia Antoniadou, Helen Giamarellou
Expert Opinion on Investigational Drugs|January 25, 2007
Investigational treatments for postoperative surgical site infectionsGaryphallia Poulakou, Helen Giamarellou
Antibiotics (Basel, Switzerland)|February 9, 2020
Carbapenem-Sparing Strategies for ESBL Producers: When and HowIlias Karaiskos, Helen Giamarellou
Drugs|September 15, 2009
Multidrug-resistant Gram-negative infections: what are the treatment options?Helen Giamarellou, Garyphallia Poulakou
Expert Opinion on Pharmacotherapy|April 29, 2014
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approachesIlias Karaiskos, Helen Giamarellou
Critical Care Clinics|March 26, 2008
Current therapies for pseudomonas aeruginosaHelen Giamarellou, Kyriaki Kanellakopoulou
Pageof 21